Aurobindo Pharma USA Inc. is recalling 9,504 bottles of Quinapril and Hydrochlorothiazide Tablets, USP (20mg/12.5mg), a medication used to treat high blood pressure. The recall was issued because testing detected an impurity known as N-Nitroso-quinapril at levels exceeding the acceptable daily intake limit set by the FDA. No illnesses or injuries related to this issue have been reported to date. Patients currently taking this medication should contact their healthcare provider or pharmacist to discuss alternative treatments or concerns.
Long-term exposure to N-Nitroso-quinapril at levels higher than the acceptable daily limit may increase the risk of cancer over time. There are currently no reported incidents or injuries linked to these specific batches of medication.
You have 2 options:
Quantity: 9504 bottles distributed.
Product label, Quinapril and Hydrochlorothiazide Tablets USP, 20mg / 12.5mg, 90 Tablets
If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.
This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.
AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.
Sources: FDA iRES · FDA Press Release · Raw API Response
openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.